FTO and lung carcinoma: In lung cancer, FTO downregulation increases m6A levels which then mediates downregulation of MZF1, a myeloid zinc finger protein 1 [24] and USP7, ubiquitin-specific protease 7 due to decreased stability of their mRNA transcripts, causing an increase in lung cancer tumorigenicity [25].